Overview Novartis, a global leader in healthcare innovation, recently embarked on a groundbreaking study introducing MIJ821 (onfasprodil), a novel therapeutic candidate for the treatment of… Read More »Novartis leveraged BNA™ technology for its first in-human study on an innovative antidepressant
Real-life data analysis conducted with a large multi-specialty health and psychiatry clinic in the US. Data was collected from 2,253 patients who visited a psychiatric… Read More »Brain Network Analytics (BNA™) in the Psychiatric Practice
Transcranial magnetic stimulation (TMS) is an effective intervention approach for patients with psychiatric disorders such as major depressive disorder (MDD) and general anxiety disorder (GAD).… Read More »Personalizing TMS Protocols with BNA™: A Case Study Demonstrating Improved Outcomes
One pivotal area where AI is making a remarkable impact is in the analysis and interpretation of electroencephalography (EEG)
BNA could improve the treatment of depression significantly by objectively measuring brain health, improving and saving lives. The BNATM Product provides brain mapping imaging technology supporting clinicians in diagnosing cognitive disorders and monitoring and quantifying improvement.
Chief Financial Officer
Chairman
Chief Marketing Officer
Chief Executive Officer
